Stocktoria

MANNATECH INC MTEX

Nasdaq · stock · Medicinal Chemicals & Botanical Products · website · IPO 1999-02-16

MANNATECH INC (MTEX) earns a Piotroski F-score of 2/9 (weak financial health), with an Altman Z″ in the distress zone. It pays a dividend yielding 7.65% (safety: no dividend). FY2025 revenue was $108.0M at a -14.1% net margin.

Chart by TradingView
16/100
Stocktoria Quality Score · grade D
2/9
Piotroski F — financial health
-1.37
Altman Z″ — distress risk · distress
5.2%
Dividend yield 5y avg · no dividend

Quality score trend · recomputed for each fiscal year

Piotroski F /9
2 3 4 6 4 8 3 4 5 2 2016201720182019202020212022202320242025
Altman Z″
3.58 3.54 1.49 2.72 2.32 3.57 1.17 0.40 1.65 -1.37 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$5.07 as of 2026-08-01 · -47.1% 1y
$4.38$10.1952-wk
Market cap USD$10M
Dividend yield 5y avg5.2%
Net margin 5y avg-2.2%
Beta0.7
Employees170

Smart money · insiders, last 12 months

Insiders net bought +$62,155 on the open market · 3 trades

Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.

Revenue trend · last 10y · down

How it ranks in Manufacturing · percentile among 1957 companies

Piotroski Fstronger than 12%
Net marginstronger than 38%
Revenue growthstronger than 16%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 2/9 tests passed

Altman Z″ components · distress zone

ComponentValue
Working capital / assets0.061
Retained earnings / assets-0.468
EBIT / assets-0.014
Equity / liabilities-0.148

Sector peers · similar-size Manufacturing companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
MTEXMANNATECH INC2/9-1.37-8.3%
NAGENiagen Bioscience, Inc.5/93.4215.7+29.9%
NAIINATURAL ALTERNATIVES INTERNATIONAL INC5/93.07+14.1%
MRMDMARIMED INC.4/9-1.76+1.3%
LEEEFLeef Brands Inc.5/9-14.11+22.1%
GLASGlass House Brands Inc.3/9-1.45-9.4%
SNYRSynergy CHC Corp.3/9-12.8%

All Manufacturing companies →

About MANNATECH INC

Mannatech, Incorporated operates as a wellness solution provider. The company develops markets and sells nutritional supplements; skin care and anti-aging products; and weight-management and fitness products. It primarily sells its products through network marketing distribution channels and e-commerce model. The company operates in the United States, Canada, Mexico, Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, the United Kingdom, Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, Thailand and China, as well as Belgium, France, Greece, Italy, Luxembourg, and Poland. Mannatech, Incorporated was incorporated in 1993 and is headquartered in Flower Mound, Texas.

FAQ

Is MTEX financially healthy?

MANNATECH INC's Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.

Does MTEX pay a dividend, and is it safe?

Yes. MANNATECH INC pays a dividend yielding about 7.65% with a None payout ratio, rated “no dividend” for safety.

How profitable is MTEX?

In FY2025, MANNATECH INC had a net margin of -14.1%.

Is MTEX overvalued or undervalued?

MANNATECH INC trades at about 3.8× trailing earnings — below its 10-year norm (10-year range 6.7×–13.0×, median 8.2×). Stocktoria reports the data, not buy/sell advice.

Is MTEX a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on MANNATECH INC: a Piotroski F-score of 2/9, an Altman Z″ in the distress zone, a dividend yield of 7.65%. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.